Discover open access scientific publications

Search, annotate, share and cite publications

Publications by L Kockler

Quality-Of-Life Findings From a Randomised Phase-Iii Study of XELOX vs FOLFOX-6 in Metastatic Colorectal Cancer

British Journal of Cancer

Cancer Research

Oncology

2009

English

Related publications

A Comparative Study of Treatment Toxicities Between FOLFOX 4 and Modified FOLFOX 6 in Iranian Colorectal Cancer Patients

Iranian Journal of Cancer Prevention

2017

English

Compliance of Patients With Locally Advanced Colorectal Cancer to Chemotherapy Using FOLFOX Compared to XELOX Regimen

The New Ropanasuri Journal of Surgery

2016

English

A Phase 2 Randomised Study of Veliparib Plus FOLFIRI±bevacizumab Versus Placebo Plus FOLFIRI±bevacizumab in Metastatic Colorectal Cancer

British Journal of Cancer

Cancer Research

Oncology

2018

English

Phase II Randomized Trial of Sequential or Concurrent FOLFOXIRI‐Bevacizumab Versus FOLFOX‐Bevacizumab for Metastatic Colorectal Cancer (STEAM)

English

Pcn390 - Metastatic Colorectal Cancer (Mcrc) - Literature Review on Quality of Life Instruments

English

A Randomised, Double-Blind, Placebo-Controlled Multi-Centre Phase III Trial of XELIRI/FOLFIRI Plus Simvastatin for Patients With Metastatic Colorectal Cancer

British Journal of Cancer

Cancer Research

Oncology

2015

English

The Clinical Benefit of Bevacizumab in Metastatic Colorectal Cancer Is Independent of K-Ras Mutation Status: Analysis of a Phase III Study of Bevacizumab With Chemotherapy in Previously Untreated Metastatic Colorectal Cancer

English

FBXW4 Acts as a Protector of FOLFOX-Based Chemotherapy in Metastatic Colorectal Cancer Identified by Co-Expression Network Analysis

Frontiers in Genetics

Genetics

Molecular Medicine

2020

English

A Phase II Study of Modified FOLFOX as First-Line Chemotherapy for Metastatic Gastric Cancer in Elderly Patients With Associated Diseases

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by L Kockler

Quality-Of-Life Findings From a Randomised Phase-Iii Study of XELOX vs FOLFOX-6 in Metastatic Colorectal Cancer

Related publications

A Comparative Study of Treatment Toxicities Between FOLFOX 4 and Modified FOLFOX 6 in Iranian Colorectal Cancer Patients

Compliance of Patients With Locally Advanced Colorectal Cancer to Chemotherapy Using FOLFOX Compared to XELOX Regimen

A Phase 2 Randomised Study of Veliparib Plus FOLFIRI±bevacizumab Versus Placebo Plus FOLFIRI±bevacizumab in Metastatic Colorectal Cancer

Phase II Randomized Trial of Sequential or Concurrent FOLFOXIRI‐Bevacizumab Versus FOLFOX‐Bevacizumab for Metastatic Colorectal Cancer (STEAM)

Pcn390 - Metastatic Colorectal Cancer (Mcrc) - Literature Review on Quality of Life Instruments

A Randomised, Double-Blind, Placebo-Controlled Multi-Centre Phase III Trial of XELIRI/FOLFIRI Plus Simvastatin for Patients With Metastatic Colorectal Cancer

The Clinical Benefit of Bevacizumab in Metastatic Colorectal Cancer Is Independent of K-Ras Mutation Status: Analysis of a Phase III Study of Bevacizumab With Chemotherapy in Previously Untreated Metastatic Colorectal Cancer

FBXW4 Acts as a Protector of FOLFOX-Based Chemotherapy in Metastatic Colorectal Cancer Identified by Co-Expression Network Analysis

A Phase II Study of Modified FOLFOX as First-Line Chemotherapy for Metastatic Gastric Cancer in Elderly Patients With Associated Diseases